## Abstract It is well known that many patients with Parkinson's disease experience neuropsychological decline. However, the nature and extent of mental status change varies widely, with some patients showing mild or no cognitive impairments and others exhibiting frank dementia. Research has shown
Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease
✍ Scribed by Lindsy N. Williams; Paul Seignourel; Gregory P. Crucian; Michael S. Okun; Ramon L. Rodriguez; Frank M. Skidmore; Paul S. Foster; Charles E. Jacobson IV; Janet Romrell; Dawn Bowers; Hubert H. Fernandez
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 70 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We studied the relationship between two screening cognitive measures and off motor Unified Parkinson's Disease Rating Scale (UPDRS) scores in 108 Parkinson's disease patients. Multiple regressions were conducted to examine the UPDRS subscores' unique contributions to cognitive function. When including bradykinesia, rigidity, and postural/gait instability subscores, only bradykinesia predicted Mini Mental Status Examination (MMSE), normalized β = −0.57, t(104) = −3.31, P < 0.01, and Dementia Rating Scale‐2 (DRS‐2), normalized β = −0.45, t(104) = −2.55, P < 0.05. Tremor was not included in the regression analyses because it did not correlate with cognitive function. When including axial and appendicular subscores, only the axial subscore predicted MMSE, normalized β = −0.39, t(105) = −3.19, P < 0.01, and DRS‐2 scores, normalized β = −0.40, t(106) = −3.28, P < 0.01. When including left‐sided and right‐sided subscores, only the right‐sided symptoms predicted DRS‐2 scores, normalized β = −0.28, t(105) = −2.45, P < 0.05, and showed a trend toward predicting MMSE scores, normalized β = −0.22, t(105) = −1.95, P = 0.054. We therefore found that right‐sided symptoms (for laterality), axial symptoms (for region), and bradykinesia (for type of symptoms) were thebest predictors of cognitive function. © 2006 Movement Disorder Society
📜 SIMILAR VOLUMES
## Abstract Recent studies have reported cognitive decline to be common in the early phase of Parkinson's disease. Imaging data connect working memory and executive functioning to the dopamine system. It has also been suggested that bradykinesia is the clinical manifestation most closely related to
## Abstract There is no consensus with regard to the clinical and neuroimaging characteristics of prodromal dementia in Parkinson's disease (PD). To delineate functional neuroimaging features of PD with mild cognitive impairment (PDMCI) and with no cognitive impairment (PDNC), we compared regional
## Abstract The Unified Parkinson's Disease Rating Scale (UPDRS) is the primary outcome measure in most clinical trials of Parkinson's disease (PD) therapeutics. Each subscore of the motor section (UPDRS III) compresses a wide range of motor performance into a coarse‐grained scale from 0 to 4; the